Researchers have uncovered three new genes that are linked to the possibility of developing Alzheimer’s disease; potentially unlocking new treatment possibilities for patients.
Novartis and Amgen have announced that Aimovig™ has been approved by the US FDA for the preventive treatment of migraine in adults.
A recent trial has determined that moderate-to-high intensity exercise does not slow cognitive decline in individuals with dementia.
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
This research article from Neurodegenerative Disease Management investigates how age and disease duration affects Parkinson’s treatment outcome with levodopa-carbidopa intestinal gel.